×
> Pharmaceuticals> North American Nuclear Medicine/Radiopharmaceuticals Market
Pharmaceuticals PH0045 January 2020 Share

North American Nuclear Medicine/Radiopharmaceuticals Market

The North American Nuclear Medicine/Radiopharmaceuticals Market is expected to grow from USD 2.33 billion in 2019 to USD 3.14 billion by 2026 at a CAGR of 4% from 2020 to 2026.

Nuclear medicine is a field that employs radioactive materials to diagnose and treat diseases. The radiopharmaceuticals used in radioactive mixtures and nuclear medicine are ordered to the patient and analyzed via particular imaging devices for therapy and diagnosis. Factors such as an increase in cases of cancer and other target conditions targeted cancer treatment with the support of alpha radioimmunotherapy, initiatives to bridge the demand-supply gap of Mo-99, convenience of treatment, implementation of clear imaging procedure, and technological advancements will act as major driving factors in the growth of the market. Application of radiopharmaceuticals in neurology and favorable government policies in developing regions will act as an opportunity for the market players in the nuclear medicine/ radiopharmaceuticals market. Nonetheless, the short half-life of radiopharmaceuticals, shortage in supply, difficulties in logistics, a dearth of skilled personnel, and lack of awareness in low-income nations will restrict the growth of nuclear medicine/ radiopharmaceuticals market.

The market is segregated on the basis of Application as Diagnostic Applications Based on Procedural Volume Assessment the market is segmented in Therapeutic Procedures and Diagnostic Procedures. Based on Type the market is segmented in Brachytherapy Isotopes, Therapeutic Nuclear Medicine, and Diagnostic Nuclear Medicine.

Competitive Rivalry

Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications, NTP Radioisotopes Soc, LTD, Cardinal Health, Curium, GE Healthcare, Lantheus Medical Imaging, Inc, Bayer AG, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The North American Nuclear Medicine/Radiopharmaceuticals market has been segmented as below:

By Application

  • Diagnostic Applications
  • PET Applications
  • Oncology
  • Cardiology
  • Neurology
  • Other PET Applications
  • Therapeutic Applications
  • Thyroid Indications
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Other Indications
  • SPECT Application
  • Cardiology
  • Bone Scans
  • Thyroid Applications
  • Pulmonary Scans
  • Other SPECT Applications

By Procedural Volume Assessment

  • Therapeutic Procedures
  • Beta Emitter Procedures
  • Alpha Emitter Procedures
  • Brachytherapy Procedures
  • Diagnostic Procedures
  • SPECT Procedures
  • PET Procedures

By Type

  • Brachytherapy Isotopes
  • Therapeutic Nuclear Medicine
  • Diagnostic Nuclear Medicine

By Company

  • Bracco Imaging S.P.A
  • Eczacibasi-Monrol Nuclear Products
  • Nordion, Inc.
  • Advanced Accelerator Applications
  • NTP Radioisotopes Soc, LTD
  • Cardinal Health
  • Curium
  • GE Healthcare
  • Lantheus Medical Imaging, Inc
  • Bayer AG

The report covers the below scope:

  • North American Nuclear Medicine/Radiopharmaceuticals market sizes from 2019 to 2026, along with CAGR for 2020-2026
  • Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2021 to 2026
  • The market trends, covering a comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2019
  • Estimated year - 2020
  • Projected year - 2021
  • Forecast period - 2021 to 2026

Report Scope:

The market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications, NTP Radioisotopes Soc, LTD, Cardinal Health, Curium, GE Healthcare, Lantheus Medical Imaging, Inc, Bayer AG, and others.

Why to Buy this Report:

  • Gain detailed insights on the North American Nuclear Medicine/Radiopharmaceuticals industry trends
  • Find a complete analysis of the market status
  • Identify the market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

                        4.2.2 Restraints

                        4.2.3 Opportunities

                        4.2.4 Challenges

            4.2 Porter's Five Force Analysis

  1. North American Nuclear Medicine/Radiopharmaceuticals Market, By Application

            5.1 Introduction

            5.2 Diagnostic Applications

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

  1. North American Nuclear Medicine/Radiopharmaceuticals Market, By Procedural Volume Assessment

            6.1 Introduction

            6.2 Therapeutic Procedures

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Diagnostic Procedures

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

  1. North American Nuclear Medicine/Radiopharmaceuticals Market, By Type

            7.1 Introduction

            7.2 Brachytherapy Isotopes

                        7.2.1 Market Overview

                        7.2.2 Market Size and Forecast

            7.3 Therapeutic Nuclear Medicine

                        7.3.1 Market Overview

                        7.3.2 Market Size and Forecast

            7.4 Diagnostic Nuclear Medicine

                        7.4.1 Market Overview

                        7.4.2 Market Size and Forecast

  1. Competitive Insights

            9.1 Key Insights

            9.2 Company Market Share Analysis

            9.3 Strategic Outlook

                        9.3.1 Mergers & Acquisitions

                        9.3.2 New Product Development

                        9.3.3 Portfolio/Production Capacity Expansions

                        9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        9.3.5 Others

  1. Company Profiles

            10.1 Bracco Imaging S.P.A

                        10.1.1 Company Overview

                        10.1.2 Product/Service Landscape

                        10.1.3 Financial Overview

                        10.1.4 Recent Developments

            10.2 Eczacibasi-Monrol Nuclear Products

                        10.2.1 Company Overview

                        10.2.2 Product/Service Landscape

                        10.2.3 Financial Overview

                        10.2.4 Recent Developments

            10.3 Nordion, Inc.

                        10.3.1 Company Overview

                        10.3.2 Product/Service Landscape

                        10.3.3 Financial Overview

                        10.3.4 Recent Developments

            10.4 Advanced Accelerator Applications

                        10.4.1 Company Overview

                        10.4.2 Product/Service Landscape

                        10.4.3 Financial Overview

                        10.4.4 Recent Developments

            10.5 NTP Radioisotopes Soc, LTD

                        10.5.1 Company Overview

                        10.5.2 Product/Service Landscape

                        10.5.3 Financial Overview

                        10.5.4 Recent Developments

            10.6 Cardinal Health

                        10.6.1 Company Overview

                        10.6.2 Product/Service Landscape

                        10.6.3 Financial Overview

                        10.6.4 Recent Developments

            10.7 Curium

                        10.7.1 Company Overview

                        10.7.2 Product/Service Landscape

                        10.7.3 Financial Overview

                        10.7.4 Recent Developments

            10.8 GE Healthcare

                        10.8.1 Company Overview

                        10.8.2 Product/Service Landscape

                        10.8.3 Financial Overview

                        10.8.4 Recent Developments

            10.9 Lantheus Medical Imaging, Inc

                        10.9.1 Company Overview

                        10.9.2 Product/Service Landscape

                        10.9.3 Financial Overview

                        10.9.4 Recent Developments

            10.10 Bayer AG

                        10.10.1 Company Overview

                        10.10.2 Product/Service Landscape

                        10.10.3 Financial Overview

                        10.10.4 Recent Developments

The North American Nuclear Medicine/Radiopharmaceuticals market has been segmented as below:

By Application

  • Diagnostic Applications
    • PET Applications
      • Oncology
      • Cardiology
      • Neurology
      • Other PET Applications
    • Therapeutic Applications
      • Thyroid Indications
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors
      • Other Indications
    • SPECT Application
      • Cardiology
      • Bone Scans
      • Thyroid Applications
      • Pulmonary Scans
      • Other SPECT Applications

By Procedural Volume Assessment

  • Therapeutic Procedures
    • Beta Emitter Procedures
    • Alpha Emitter Procedures
    • Brachytherapy Procedures
  • Diagnostic Procedures
    • SPECT Procedures
    • PET Procedures

By Type

  • Brachytherapy Isotopes
  • Therapeutic Nuclear Medicine
  • Diagnostic Nuclear Medicine

By Company

  • Bracco Imaging S.P.A
  • Eczacibasi-Monrol Nuclear Products
  • Nordion, Inc.
  • Advanced Accelerator Applications
  • NTP Radioisotopes Soc, LTD
  • Cardinal Health
  • Curium
  • GE Healthcare
  • Lantheus Medical Imaging, Inc
  • Bayer AG

FAQ's

The global North American Nuclear Medicine/Radiopharmaceuticals market size is expected to surpass USD 3.14 billion by 2026.

Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications, NTP Radioisotopes Soc, LTD, Cardinal Health, Curium, GE Healthcare, Lantheus Medical Imaging, Inc, Bayer AG, and others the key players in the global North American Nuclear Medicine/Radiopharmaceuticals market. We provide minimum 10 company profile in the report.

The alpha emitters type segment is expected to command the largest share of the therapeutic nuclear medicine market in 2019.

An instant invoice is sent to you through email once the payment process is completed.

Market Reports Library offers report customizations according to the client requirements, as we understand that the client requirements may not be solely satisfied by our syndicated reports. We offer a dedicated team for the customizations offering maximum value output for the money spent by client. The modifications of report scope and additional insights are provided free as post-sale support to an extent of 10% of the report cost.

Yes, the individual sections of the report can be purchased. Please contact our sales representative to assist you in this regard.

  • North America
  • 180Pages
  • ProMarket Research
License Options


 

Subscribe our Newsletter

Please Subscribe for exciting offers and for new reports.
Important Links
Social Media Links
Contact Us

SRR residency Kphb colony,
Near prathibha school Mig-59,
7th phase 500072,
Hyderabad.

phone call image +91 8928545557